Gary R. Lichtenstein, M.D.
Professor of Medicine at the Hospital of the University of Pennsylvania
Director, IBD Program, Hospital of the University of Pennsylvania
Department: Medicine
Contact information
Hospital of the University of Pennsylvania
3 Ravdin
3400 SPruce Street
Philadelphia, PA 19104
3 Ravdin
3400 SPruce Street
Philadelphia, PA 19104
Office: 215-349-8222
Fax: 215-349-5915
Fax: 215-349-5915
Email:
GRL@uphs.upenn.edu
GRL@uphs.upenn.edu
Publications
Education:
BA (Chemistry)
University of Pennsylvania, 1980.
MD
Mount Sinai School of Medicine, 1984.
BA (Chemistry)
University of Pennsylvania, 1980.
MD
Mount Sinai School of Medicine, 1984.
Post-Graduate Training
Intern in Medicine, Duke University Medical Center, 1984-1985.
Resident in Medicine, Duke University Medical Center, 1985-1987.
Fellow in Gastroenterology, Hospital of the University of Pennsylvania, 1987-1990.
Permanent linkIntern in Medicine, Duke University Medical Center, 1984-1985.
Resident in Medicine, Duke University Medical Center, 1985-1987.
Fellow in Gastroenterology, Hospital of the University of Pennsylvania, 1987-1990.
Description of Clinical Expertise
Inflammatory Bowel DiseaseCrohn's Disease
Ulcerative Colitis
Selected Publications
Feagan BG, Sandborn WJ, Lichtenstein GR, Radford-Smith G, Patel J, Innes A.: CDP571, A Humanized Monoclonal Antibody in Tumor Necrosis Factor [alpha], for Steroid-Dependent Crohn’s Disease: A Randomized, Double-Blind, Placebo-controlled trial. Alimentary Pharmacology Therapeutics 2006.Lichtenstein GR. Abreu M, Cohen R, Tremaine W. Position Paper: Corticosteroids Immunomodulators in Inflammatory Bowel Disease. Gastroenterology 2006.
Osterman MT, Kundu R, Lichtenstein GR, Lewis G: Association of 6- Thioguanine Nucleotide levels and Inflammatory Bowel Disease Activity: A Meta-Analysis. Gastroenterology 2006.
Lichtenstein GR, Feagan BG, Cohen RD, Salzberg BA, Diamond RH, Chen DM, Pritchard ML, Sandborn WJ: Risk of Serious Infections and Mortality in Association with Infliximab and Other Therapies for Crohn’s Disease: TREAT™ Registry. Clinical Gastroenterology and Hepatology 2006.
Lichtenstein GR: Factors Associated with the Development of Intestinal Strictures or Obstruction in Patients with Crohn’s Disease. American Journal of Gastroenterology 2006.
Chhablani R and Lichtenstein GR: Medical Therapy of Inflammatory Bowel Disease Conn’s Textbook of Medicine 2006.
Su C, Lewis JD, Goldberg B,, Brensinger C, Lichtenstein GR: A Meta-Analysis of the Placebo Rates of Remission and Response in Clinical Trials of Active Ulcerative Colitis. Gastroenterology 2006.
Hass D, Lichtenstein GR: The Impact of Elevated Body Mass Index on the Clinical Course of Crohn's Disease. Clinical Gastroenterology and Hepatology 2006.
Seidner DL, Lashner BA, Brezinski A, Banks PLC, Goldblum J, Fiocchi C, Katz J, Lichtenstein GR, Anton P, Kam LY, Garleb KA, DeMichele SJ and the enteral nutrition in Ulcerative Colitis Study Group: A Novel Nutritional Supplement Reduces Corticosteroid Requirements in Patients with Ulcerative Colitis: A Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial. Clinical Gastroenterology and Hepatology 2005.
Campbell MS, Lichtenstein GR, Rhim AD, Pazianas M, and Faust T: Severity of liver disease does not predict osteopenia or low bone mineral density in primary sclerosing cholangitis. Liver International 2005.
